Despite the proven efficacy of antidepressants in treating depression, a recent study has emphasized the growing concern of ...
President Donald Trump’s pick to lead the Food and Drug Administration, Dr. Marty Makary, was confirmed by the Senate late ...
Antidepressant discontinuation syndrome can cause symptoms such as nausea, headaches, diarrhea, or even reoccurrence of ...
Increasing numbers of young adults in high-stress careers are turning to amphetamines to maintain their rapid pace. But these ...
Too few people get diagnosed and treated for postpartum depression. But a blood test could change that Postpartum depression ...
Some Kentuckians who’ve taken SSRIs to treat depression are angry and confused over Trump administration rhetoric surrounding ...
A new study has found that antidepressant resistance is more common than was thought: 48% of people with depression have ...
Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
SSRIs are not addictive and cannot change your personality or make you more violent. It's important not to stigmatize psychiatric medication, as mental illness is already so stigmatized.
The study evaluates 20 years of the US Food and Drug Administration (FDA) Adverse Event Reporting System data.
The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...
Almost half of patients diagnosed with depression classify as being 'treatment-resistant' as new research suggests that many don't respond to multiple antidepressant options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback